Alpha 2.0
Login Register
» Articles » PMID: 36751373

Cervical Cancer Screening Coverage - China, 2018-2019

Overview
Journal China CDC Wkly
Date 2023 Feb 8
PMID 36751373
Authors
Mei Zhang
Yijing Zhong
Limin Wang
Heling Bao
Zhengjing Huang
Zhenping Zhao
Xiao Zhang
Chun Li
Kelly Liang Sun
Jing Wu
Xiaoying Zheng
Linhong Wang
Affiliations
Soon will be listed here.
Abstract

What Is Already Known About This Topic?: The World Health Organization set a 2030 target of 70% cervical cancer screening coverage for women aged 35-45 years. Coverage stood at 37% in China in 2015.

What Is Added By This Report?: In 2018-2019, China's cervical cancer screening coverage reached 43.4% in women aged 35-44 years and 36.8% in women aged 35-64 years. Screening coverage was still lower in rural areas as well as central and western regions; large variations existed across provincial-level administrative divisions.

What Are The Implications For Public Health Practice?: National and local policy and financial support should be maintained for cervical cancer screening, along with more targeted health education and outreach efforts and strengthened accessibility of health services in the rural areas and central and western regions.

Citing Articles

Benefits and challenges of cervical cancer screening since the implementation of the 'two cancer' screening programme in China: findings from Shangyu, Zhejiang in 2019-23.

Wu Y, Luo J, Ye D, Gao S J Glob Health. 2025; 15:04064.

PMID: 40048317 PMC: 11884646. DOI: 10.7189/jogh.15.04064.

Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study.

Alfaro T, Martinez-Folgar K, Stern D, Wilches-Mogollon M, Munoz M, Quick H Lancet Glob Health. 2025; 13(2):e268-e276.

PMID: 39890227 PMC: 11782990. DOI: 10.1016/S2214-109X(24)00446-7.

Epidemiological study of HPV infection in 24,588 rural women in Luonan, China.

Zhao X, Shen S, Su C, Chang J, Yan Y, Zhao J Gynecol Oncol Rep. 2025; 57():101669.

PMID: 39834647 PMC: 11743901. DOI: 10.1016/j.gore.2024.101669.

Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study.

Zou Z, Fairley C, Ong J, Shen M, Chow E, Liu H EClinicalMedicine. 2025; 77:102878.

PMID: 39763509 PMC: 11701475. DOI: 10.1016/j.eclinm.2024.102878.

Assessment of and methylation triage efficacy across HPV genotypes and age groups in high-risk HPV-positive women in China.

Liang H, Liu Y, Yin S, Jiang M, Dou Q, Wang H Front Oncol. 2024; 14:1481626.

PMID: 39659794 PMC: 11628385. DOI: 10.3389/fonc.2024.1481626.

References
1.
Zheng R, Sun K, Zhang S, Zeng H, Zou X, Chen R . [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi. 2019; 41(1):19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.005. View
2.
Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R . Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022; 10(8):e1115-e1127. PMC: 9296658. DOI: 10.1016/S2214-109X(22)00241-8. View
3.
Bao H, Wang L, Wang L, Fang L, Zhang M, Zhao Z . [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018; 39(2):208-212. DOI: 10.3760/cma.j.issn.0254-6450.2018.02.014. View
4.
Zhang M, Zhong Y, Zhao Z, Huang Z, Zhang X, Li C . Cervical Cancer Screening Rates Among Chinese Women - China, 2015. China CDC Wkly. 2021; 2(26):481-486. PMC: 8393124. DOI: 10.46234/ccdcw2020.128. View
5.
Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T . Cancer incidence and mortality in China, 2013. Cancer Lett. 2017; 401:63-71. DOI: 10.1016/j.canlet.2017.04.024. View